title: Fourteen week clinical evaluation of an oral antioxidant as a treatment for osteoarthritis secondary to canine hip dysplasia.
authors.affiliation: Syosset Animal Hospital, NY 11791, USA.
authors.forename: J A
authors.initials: JA
authors.lastname: Impellizeri
authors.forename: R E
authors.initials: RE
authors.lastname: Lau
authors.forename: F A
authors.initials: FA
authors.lastname: Azzara
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D004283:Dog Diseases / Q000209:etiology*; D004285:Dogs; D004311:Double-Blind Method; D006619:Hip Dysplasia, Canine / Q000150:complications*; D009930:Organic Chemicals; D010003:Osteoarthritis / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary*; D014815:Vitamins / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000975:Antioxidants; D009930:Organic Chemicals; D014815:Vitamins; C114446:proanthozone